![David T. Hagerty](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
David T.
Hagerty worked as an Executive Director of Immunology at Bristol-Myers Squibb Pharmaceutical Research Institute from 1997 to 2006.
He then worked as Vice President of Immunology and Rheumatology at Biogen Idec, Inc. from 2006 to 2011.
From 2011 to 2013, he served as Chief Medical Officer and Senior Vice President at Ardea Biosciences, Inc. He was also the Executive Vice President of Clinical Development at Conatus Pharmaceuticals, Inc. from 2014 to 2019.
Hagerty received his undergraduate degree from the University of Notre Dame in 1977 and his doctorate from Saint Louis University School of Medicine in 1981.
Anciens postes connus de David T. Hagerty
| Sociétés | Poste | Fin |
|---|---|---|
| HISTOGEN INC. | Corporate Officer/Principal | 30/09/2019 |
Ardea Biosciences, Inc.
 Ardea Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops small molecule therapeutics | Directeur Technique/Scientifique/R&D | 01/01/2013 |
Biogen Idec, Inc. (North Carolina)
 Biogen Idec, Inc. (North Carolina) Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Corporate Officer/Principal | 01/01/2011 |
Bristol-Myers Squibb Pharmaceutical Research Institute | Corporate Officer/Principal | 01/01/2006 |
Formation de David T. Hagerty
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
75
Relations au 1er degré
6
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
University of Notre Dame
 University of Notre Dame Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Conatus Pharmaceuticals, Inc.
 Conatus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company, which engages in the development of human therapeutics to treat liver diseases | Health Technology |
Ardea Biosciences, Inc.
Ardea Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops small molecule therapeutics | Health Technology |
Biogen Idec, Inc. (North Carolina)
Biogen Idec, Inc. (North Carolina) Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Bristol-Myers Squibb Pharmaceutical Research Institute | |
Saint Louis University School of Medicine
 Saint Louis University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
